Replay available

Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call

Thermo Fisher Scientific Inc (NYSE: TMO) Q2 2026 earnings conference call, held 2026-07-23. Replay captured from the company's public earnings webcast.

Thu, July 23, 2026 at 8:30 AMendedReplay
Thermo Fisher Scientific Inc (TMO) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Rafael Tejada

Vice President, Investor Relations

Marc Casper

Chairman and Chief Executive Officer

Jim Meyer

Senior Vice President and Chief Financial Officer

Michael Riskin

Analyst, Bank of America

Tycho Peterson

Analyst, Jefferies

Jack Meehan

Analyst, Operin Research

Matt LaRue

Analyst, William Blair

Dan Arias

Analyst, Stifle

Dan Brennan

Analyst, TD Cohen

Patrick Donnelly

Analyst, Citi

Luke Surgot

Analyst, Barclays

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2026 second quarter conference call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I would like to introduce our moderator for the call, Mr. Rafael Tejada, Vice President, Investor Relations. Mr. Tejada, you may begin the call. Good morning, and thank you for joining us. On the call with me today is Marc Casper, our chairman and chief executive officer, and Jim Meyer, senior vice president and chief financial officer. Please note this call is being webcast live and will be archived on the investor section of our website, thermofisher.com, under the heading News, Events, and Presentations, until October 20th, 2026. A copy of the press release of our second quarter earnings is available in the investor section of our website under the heading financials. So before we begin, let me briefly cover our safe harbor statement. Various remarks that we may make about the company's future expectations Plans and prospects constitute forward-looking statements within the meaning of applicable securities laws. Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties, including those discussed in the company's most recent reports on Form 10-K and Form 10-Q under the heading Risk Factors. These forward-looking statements are based on our current expectations and speak only as of the date they are made. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even in the event of new informa...

More from Thermo Fisher Scientific Inc